| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455
The mechanism by which TCR antagonists interfere with T cell activation is unclear. One popular hypothesis is that incomplete early signaling events induced by these ligands dominantly inhibit the T cell’s ability to respond to a copresented agonist ligand. Here we test this "dominant negative" signal hypothesis by studying T cells expressing two distinct MHC class I-restricted TCRs (2C and OT-I). Although responses through each TCR can be efficiently inhibited by their specific antagonists, we found no evidence for "cross-antagonism" in which an antagonist for receptor "A" blocks responses through receptor "B." Such inhibition would have been expected were the dominant negative signaling hypothesis correct, and alternative models for TCR antagonism are discussed.
This article has been cited by other articles:
|
|
 |
|
  D. S. Jones, P. Reichardt, M. L. Ford, L. J. Edwards, and B. D. Evavold TCR Antagonism by Peptide Requires High TCR Expression J. Immunol., August 1, 2008; 181(3): 1760 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. James, P. D. Greenberg, M. C. Jensen, Y. Lin, J. Wang, B. G. Till, A. A. Raubitschek, S. J. Forman, and O. W. Press Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane J. Immunol., May 15, 2008; 180(10): 7028 - 7038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kao, M. A. Daniels, and S. C. Jameson Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation Int. Immunol., December 1, 2005; 17(12): 1607 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O. Holman, E. R. Walsh, and S. C. Jameson Characterizing the Impact of CD8 Antibodies on Class I MHC Multimer Binding J. Immunol., April 1, 2005; 174(7): 3986 - 3991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sumen, M. L. Dustin, and M. M. Davis T cell receptor antagonism interferes with MHC clustering and integrin patterning during immunological synapse formation J. Cell Biol., August 16, 2004; 166(4): 579 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Mueller, M. A. Daniels, A. Felthauser, C. Kao, S. C. Jameson, and Y. Shimizu Cutting Edge: LFA-1 Integrin-Dependent T Cell Adhesion Is Regulated by Both Ag Specificity and Sensitivity J. Immunol., August 15, 2004; 173(4): 2222 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Pitcher, P. S. Ohashi, and N. S. C. van Oers T Cell Antagonism is Functionally Uncoupled from the 21- and 23-kDa Tyrosine-Phosphorylated TCR {zeta} Subunits J. Immunol., July 15, 2003; 171(2): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yang and H. M. Grey Study of the Mechanism of TCR Antagonism Using Dual-TCR-Expressing T Cells J. Immunol., May 1, 2003; 170(9): 4532 - 4538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Vilen, K. M. Burke, M. Sleater, and J. C. Cambier Transmodulation of BCR Signaling by Transduction- Incompetent Antigen Receptors: Implications for Impaired Signaling in Anergic B Cells J. Immunol., May 1, 2002; 168(9): 4344 - 4351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Legrand and A. A. Freitas CD8+ T Lymphocytes in Double {alpha}{beta} TCR Transgenic Mice. I. TCR Expression and Thymus Selection in the Absence or in the Presence of Self-Antigen J. Immunol., December 1, 2001; 167(11): 6150 - 6157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Peydro, A. Paradela, J. P. Albar, and J. A. L. d. Castro Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope J. Immunol., November 15, 2000; 165(10): 5680 - 5685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Daniels and S. C. Jameson Critical Role for CD8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers J. Exp. Med., January 17, 2000; 191(2): 335 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Kersh, G. J. Kersh, and P. M. Allen Partially Phosphorylated T Cell Receptor {zeta} Molecules Can Inhibit T Cell Activation J. Exp. Med., December 6, 1999; 190(11): 1627 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Robertson and B. D. Evavold Cutting Edge: Dueling TCRs: Peptide Antagonism of CD4+ T Cells with Dual Antigen Specificities J. Immunol., August 15, 1999; 163(4): 1750 - 1754. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
